BLGO · Biolargo, Inc.
$0.12
+0.01 (+9.09%)
At close · Jul 21
Going-concern doubt
— flagged May 15, 2026
Substantial doubt about the company's ability to continue as a going concern.
“The foregoing factors raise substantial doubt about our ability to continue as a going concern, unless we are able to increase revenues, generate cash from operations, and/or generate cash from financing activities.”View the 10-Q filed May 15, 2026
Market Cap
$38.51M
Shares
320.88M
Income-statement, balance-sheet and cash-flow figures extracted from the company's SEC filings — 10-K annual and 10-Q quarterly reports — and standardised for comparison across periods.
Revenue
$7.77M
-56.3%
FY2025
Net Income
-$15.19M
-249.4%
FY2025
Gross Margin
43.86%
-0.3pp
FY2025
Operating Margin
-191.31%
-167pp
FY2025
Operating Cash Flow
-$8.3M
-158.8%
FY2025
Chart any reported metric, KPI or segment over time — the full statement history lives here
Search above to add metrics — fundamentals, product and segment revenue, company KPIs, valuation.
| Line Item | TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| $5.61M | $7.77M | $17.78M | $12.23M | $5.88M | $2.53M | $2.43M | $1.86M | $1.36M | $516.21K | $281.11K | $127.58K | $111.55K | $167.95K | $65.54K | $156.19K | |
| -$391K | -$340K | -$33K | -$91K | — | — | — | — | — | — | — | — | — | — | — | — | |
| $3.24M | $4.36M | $9.93M | $6.08M | $3.03M | $1.43M | $1.2M | $945K | $743K | $322.72K | $105.88K | $62.07K | $56K | $29.66K | $39.78K | $44.76K | |
| $2.38M | $3.41M | $7.85M | $6.15M | $2.86M | $1.1M | $1.23M | $916K | $621K | $193.5K | $175.23K | $65.52K | $55.55K | $138.29K | $25.76K | $111.43K | |
| — | 43.86% | 44.17% | 50.32% | 48.56% | 43.58% | 50.49% | 49.22% | 45.53% | 37.48% | 62.34% | 51.35% | 49.8% | 82.34% | 39.3% | 71.34% | |
| $2.71M | $2.59M | $2.88M | $2.28M | $1.32M | $1.37M | $1.34M | $1.47M | $1.72M | $1.63M | $1.38M | $684.55K | $642.92K | $742.25K | $126.02K | $99.5K | |
| $12M | $11.77M | $9.3M | $8.06M | $6.73M | $6.17M | $7.47M | $6.14M | $5.26M | $4.43M | $3.71M | $3.55M | $2.79M | $2M | $4.61M | $3.17M | |
| — | — | — | — | — | — | — | — | — | $10.92K | $10.92K | $10.92K | $10.92K | — | — | — | |
| — | — | — | $103K | $45K | $20K | $58K | $65K | $50K | $29.84K | $13.74K | $10.92K | $10.92K | $10.92K | $5430 | $7866 | |
| $18.57M | $18.26M | $12.18M | $10.73M | $8.25M | $7.54M | $8.81M | $7.61M | $7.03M | — | — | $4.25M | $3.45M | $2.76M | $4.74M | $3.27M | |
| -$16.2M | -$14.86M | -$4.33M | -$4.58M | -$5.39M | -$6.44M | -$7.58M | -$6.7M | -$6.41M | -$5.9M | -$4.93M | -$4.18M | -$3.39M | -$2.62M | -$4.72M | -$3.16M | |
| — | -191.31% | -24.36% | -37.45% | -91.6% | -254.29% | -311.8% | -359.81% | -470.09% | -1141.98% | -1755.52% | -3277.49% | -3040.35% | -1559.82% | -7197.88% | -2023.91% | |
| — | — | — | -$4.48M | -$5.35M | -$6.42M | -$7.53M | -$6.63M | -$6.36M | -$5.87M | -$4.92M | -$4.17M | -$3.38M | -$2.61M | -$4.71M | -$3.15M | |
| — | $540K | — | $91K | $53K | $234K | $1.92M | $4M | $3.49M | $3.86M | $3.13M | $994.67K | $348.15K | $281.59K | $616.35K | $793.26K | |
| $244K | $200K | $33K | — | — | — | — | — | — | — | — | — | — | — | — | — | |
| -$476K | -$334K | -$16K | -$68K | $258K | -$458K | -$2.12M | -$4.74M | -$4.28M | -$3.65M | — | — | — | — | — | -$793.26K | |
| -$16K | -$14K | -$5000 | -$14K | -$15K | -$15K | -$37K | — | — | — | — | — | — | — | — | — | |
| — | -$15.19M | — | — | — | — | — | — | — | — | — | — | — | — | — | — | |
| — | — | $0 | — | — | — | — | — | — | — | — | — | — | — | — | — | |
| -$16.67M | -$15.19M | -$4.35M | -$4.65M | -$5.13M | -$6.89M | -$9.7M | -$11.44M | -$10.7M | -$9.55M | -$8.07M | -$5.08M | -$3.69M | -$2.53M | -$5.33M | -$3.95M | |
| — | -195.61% | -24.45% | -38% | -87.22% | -272.38% | -398.85% | -614.72% | -784.16% | -1849.34% | -2872.35% | -3979.42% | -3309.92% | -1505.44% | -8138.27% | -2531.8% | |
| -$3.76M | -$3.41M | -$1.95M | -$1.14M | -$659K | — | — | — | — | — | -$234.6K | -$21.05K | -$47.45K | -$372.92K | — | — | |
| -$12.91M | -$11.78M | -$2.4M | -$3.5M | -$4.47M | -$7.08M | -$8.43M | -$10.69M | -$10.22M | -$9.12M | -$7.84M | -$5.06M | — | — | — | — | |
| -$12.92M | -$11.8M | -$2.31M | -$3.63M | -$4.51M | -$7.09M | -$8.43M | -$10.7M | -$10.25M | -$9.1M | -$7.88M | — | — | — | — | — | |
| USD/shares | — | -$0.04 | -$0.01 | -$0.02 | -$0.02 | — | — | — | — | — | — | — | — | — | — | — |
| shares | — | 306.95M | 298.12M | 285.96M | 268.3M | 247.2M | 195.99M | 152.09M | 122M | 98.94M | 87.94M | 84.11M | 80.02M | 72.95M | 63.75M | 55.71M |
Italic rows are computed from reported lines — open a row's info icon for its formula. Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing.
TTM: trailing twelve months through the latest reported quarter — flows sum the last four quarters, balances take the latest. 3Y/5Y/10Y columns are trailing CAGR from the newest fiscal year; blank where an endpoint is missing or negative.
Price & Valuation
Multiples computed on the strict TTM/EV methodology — today's snapshot against the industry, and each ratio recomputed as of past filing dates.
Valuation
EV/Revenue
—
Chemicals median 0.87×
EV/EBIT
—
P/E (TTM)
—
Chemicals median 39.11×
Valuation over time computed as of each quarter's filing date
Revenue Breakdown
Annual revenue as the company disaggregates it in its own XBRL filings. Years a component wasn't reported show a dash.
Share mode is each component's slice of the reported components that year — issuers rarely tag every revenue dollar, so slices need not sum to total revenue.
By Segment (USD)
| Component | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Odor No More | $5,905,000 | $15,597,000 | $11,440,000 | $4,374,000 | $1,419,000 | $1,568,000 |
| Biolargo Engineering Science Technologies LLC | $2,545,000 | $3,197,000 | $2,397,000 | $1,943,000 | $1,635,000 | $1,050,000 |
| Biolargo Canada | $86,000 | $72,000 | $30,000 | $1,000 | — | — |
| Clyra Segment | $0 | $0 | $20,000 | $56,000 | $139,000 | $240,000 |
| Biolargo Water | — | — | — | $1,000 | $12,000 | $37,000 |
By Product & Service (USD)
| Component | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Product | $5,767,000 | $16,762,000 | $11,460,000 | $4,434,000 | $1,572,000 | $1,825,000 |
| Service | $1,998,000 | $1,017,000 | $770,000 | $1,450,000 | $959,000 | $607,000 |
Segment Operating Income
Annual operating income by business segment, as tagged in the company's own XBRL filings. Segments need not sum to the consolidated figure — corporate costs and eliminations are typically unallocated.
By Segment (USD)
| Component | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Best | -$276,000 | -$273,000 | $0 | — | — | — |
| Biolargo Canada | -$534,000 | -$532,000 | -$695,000 | -$714,000 | — | — |
| Biolargo Energy Technologies Inc BETI | -$639,000 | -$642,000 | -$1,179,000 | $0 | — | — |
| Biolargo Engineering Science Technologies LLC | -$1,091,000 | -$1,453,000 | -$1,619,000 | -$452,000 | -$629,000 | -$619,000 |
| Odor No More | -$2,317,000 | $5,920,000 | $4,335,000 | $1,130,000 | -$511,000 | -$493,000 |
| Clyra Segment | -$6,065,000 | -$3,324,000 | -$2,102,000 | -$1,383,000 | $666,000 | -$1,827,000 |
| Biolargo Water | — | — | — | -$714,000 | -$616,000 | -$697,000 |
Operating Margin by Segment (%)
| Component | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Odor No More | -39.2% | 38% | 37.9% | 25.8% | -36% | -31.4% |
| Biolargo Engineering Science Technologies LLC | -42.9% | -45.4% | -67.5% | -23.3% | -38.5% | -59% |
| Biolargo Canada | -620.9% | -738.9% | -2316.7% | -71400% | — | — |
| Clyra Segment | — | — | -10510% | -2469.6% | 479.1% | -761.3% |
| Biolargo Water | — | — | — | -71400% | -5133.3% | -1883.8% |